X-linked inhibitor of apoptosis regulates T cell effector function

Area of Science:

• Immunology
• Neuroscience
• Molecular Biology

Background:

• The balance of pro- and anti-apoptotic signals is crucial for immune system effector function.
• X-linked inhibitor of apoptosis (XIAP) is an endogenous regulator of cellular apoptosis.
• XIAP expression is implicated in autoimmune diseases.

Purpose of the Study:

• To investigate the role of XIAP in experimental autoimmune encephalomyelitis (EAE).
• To evaluate the therapeutic potential of targeting XIAP using antisense oligonucleotides (ASO-XIAP).

Main Methods:

• Real-time PCR to measure XIAP expression in EAE mice.
• Administration of ASO-XIAP to EAE mice (daily, prophylactic).
• Flow cytometry and TUNEL/Annexin V staining to assess T cell apoptosis in the central nervous system (CNS).

Main Results:

• XIAP expression increased with EAE severity.
• ASO-XIAP treatment reduced XIAP expression and alleviated EAE, preventing relapses.
• ASO-XIAP treatment significantly reduced T cell infiltration in the CNS and increased T cell apoptosis.
• No adverse effects observed in neurons, oligodendrocytes, or liver.

Conclusions:

• XIAP is a critical regulator of effector T cell apoptotic susceptibility.
• Targeting XIAP with ASO-XIAP is a promising therapeutic strategy for autoimmune diseases like EAE.